BerandaAGIO • BMV
add
Agios Pharmaceuticals Inc
Tutup sebelumnya
$983,02
Rentang tahun
$397,93 - $983,02
Kapitalisasi pasar
3,18Â M USD
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 8,96Â jt | 21,15% |
Biaya operasional | 38,54Â jt | 49,24% |
Laba bersih | 947,92Â jt | 1.137,97% |
Margin laba bersih | 10,57Â rb | 956,76% |
Penghasilan per saham | -1,47 | 10,66% |
EBITDA | -101,47Â jt | -2,21% |
Tarif pajak efektif | 5,31% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 1,00Â M | 55,18% |
Total aset | 1,79Â M | 77,89% |
Total liabilitas | 165,12Â jt | 37,13% |
Total ekuitas | 1,63 M | — |
Saham yang beredar | 57,03 jt | — |
Harga terhadap nilai buku | 34,46 | — |
Tingkat pengembalian aset | -20,04% | — |
Tingkat pengembalian modal | -21,31% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 947,92Â jt | 1.137,97% |
Kas dari operasi | -84,22Â jt | -36,62% |
Kas dari investasi | 250,79Â jt | 537,49% |
Kas dari pembiayaan | 2,64Â jt | 40,12% |
Perubahan kas bersih | 169,21Â jt | 928,66% |
Arus kas bebas | -3,03Â jt | 95,64% |
Tentang
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Didirikan
2008
Situs
Karyawan
385
